Half of Canadian men aged 50 (47.5%) reported a lifetime PSA screening event [35], while Kabore [92] indicated that most participants (70.3%, n = 422) were unaware of any screening tests for prostate cancer being available. This evidence concerns the gene KLK3 and prostate carcinoma.